First Australian Transapical Mitral Valve-in-Valve Implant for a Failed Mitral Bioprosthesis: How To Do It

Transcatheter aortic valve replacements lower mortality in patients not suitable for surgical valve replacement compared to conservative treatment. Transcatheter valve-in-valve implants have been shown to be feasible in failed bioprostheses in aortic, mitral, pulmonary and tricuspid positions. We re...

Full description

Saved in:
Bibliographic Details
Published inHeart, lung & circulation Vol. 21; no. 11; pp. 737 - 739
Main Authors Poon, Karl K.C., MBBS, FRACP, Clarke, Andrew, MBBS, FRACS, Luis, Sushil A., MBBS, Wiemers, Paul, MBBS, Incani, Alexander, MBBS, FRACP, Scalia, Gregory, MBBS, FRACP, Tesar, Peter, MBBS, FRACS, FCSANZ, Raffel, Owen Christopher, MBChB, FRACP, Aroney, Constantine N., MBBS, MD, FRACP, FCSANZ, Walters, Darren L., MBBS, MPhil, FRACP, FCSANZ
Format Journal Article
LanguageEnglish
Published Australia Elsevier B.V 01.11.2012
Subjects
Online AccessGet full text

Cover

Loading…
More Information
Summary:Transcatheter aortic valve replacements lower mortality in patients not suitable for surgical valve replacement compared to conservative treatment. Transcatheter valve-in-valve implants have been shown to be feasible in failed bioprostheses in aortic, mitral, pulmonary and tricuspid positions. We report the first Australasian experience of a transapical mitral valve-in-valve placement with an Edwards Sapien® transcatheter valve for a failed mitral bioprosthesis, focussing on the technical aspects of this novel procedure. Whilst the evidence for this niche indication is limited currently to case reports and case series, further evaluation of its long term outcomes may justify its use in this particularly high risk group of re-do sternotomy patients.
Bibliography:ObjectType-Case Study-2
SourceType-Scholarly Journals-1
ObjectType-Feature-4
content type line 23
ObjectType-Report-1
ObjectType-Article-3
ISSN:1443-9506
1444-2892
DOI:10.1016/j.hlc.2012.04.006